Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
03/2012
03/28/2012EP1694775B1 Reagent for detecting an analyte
03/28/2012CN102395593A Production and use of zinc amides
03/28/2012CN102395563A Process for the preparation of a biphenyl-2-ylcarbamic acid ester
03/28/2012CN102395560A Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
03/28/2012CN102391294A Chiral rare earth complex and preparation method and application thereof
03/28/2012CN102391222A Novel hydroxamates as therapeutic agents
03/28/2012CN102391174A Preparation method of clevidipine butyrate intermediate
03/28/2012CN102391173A Cilnidipine compound and preparation method thereof
03/28/2012CN101691351B Synthesis method of 4-aminopropenylphenyl-1,4-dihydropyridine and medicinal application thereof
03/28/2012CN101397270B Polymorphic substance of donepezil salt, preparation and use thereof
03/27/2012US8143416 Alternative synthesis of renin inhibitors and intermediates thereof
03/27/2012US8143411 Substituted 6-phenylnicotinic acids and their use
03/27/2012US8143410 Kinase inhibitors
03/27/2012US8143404 N-heterocycle urea compounds such as 5-([(butyl{1-[(2-methyl-6-{4-[(methylsulfonyl)amino]phenoxy)-3-pyridinyl)methyl]-4-piperidinyl}amino)carbonyl]amino)-2,4-difluorobenzamide; chemokine receptor CCR5 antagonists for various inflammatory diseases, autoimmune diseases, infectious diseases
03/27/2012CA2698500C Creatine sugar amides and salts thereof
03/27/2012CA2533431C Process for the hydrogenation of aromatic compounds
03/27/2012CA2526991C Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic m3 receptor
03/22/2012US20120071660 Resolution of (±)-methyl phenyl[4-[4-[[[4'(trifluoromethyl)-2- biphenylyl]carbonyl]amino]phenyl]-1-piperidinyl]acetate
03/22/2012US20120071659 Process for the Preparation of Sufentanil Base and Related Compounds
03/22/2012US20120071482 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
03/22/2012US20120071319 Spiroheterocyclic furan and thiofuran dione derivatives
03/22/2012US20120070781 Base generator, photosensitive resin composition, pattern forming material comprising the photosensitive resin composition, pattern forming method using the photosensitive resin composition and products comprising the same
03/21/2012EP1942733B1 Radiolabeled glycine transporter inhibitors
03/21/2012EP1761495B1 Piperidinyl prostaglandin analogs as ocular hypotensive agents
03/21/2012CN1984895B Synthesis and uses of synephrine derivatives
03/21/2012CN102382041A Preparation method of amlodipine maleate
03/21/2012CN102382040A Preparation of nifedipine and impurity separation method and application thereof
03/21/2012CN102382039A Synthesizing technology of hindered amine light stabilizer Tinuvin-770
03/21/2012CN101466694B Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
03/21/2012CN101296969B Novel alkoxyamines containing unsaturated groups
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138357 Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field
03/20/2012US8138259 Polyamide molding materials with an improved flowability, the production thereof and its use
03/20/2012US8138206 Piperidine derivative
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012US8138177 Benzimidazolone derivatives as CB2 receptor ligands
03/20/2012CA2504410C Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof
03/20/2012CA2453510C Treatment of fatigue and cognitive side effects associated with cancer, cancer treatments and menopause with d-threo-methyphenidate
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012US20120065398 Method for producing 3-amidinophenylalanine derivatives
03/15/2012US20120065389 Method for recovery/reuse of n-oxyl compound
03/15/2012US20120065358 Biodegradable poly(beta-amino esters) and uses thereof
03/15/2012US20120065230 Nitroxide Free Radical Synergized Antineoplastic Agents
03/15/2012US20120065206 Compounds for treating proliferative disorders
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012CA2810489A1 Prostaglandin d synthase inhibitory piperidine compounds
03/14/2012EP2427432A2 Novel heterocyclic compounds
03/14/2012EP2427429A1 Carboxamide compounds and their use as calpain inhibitors
03/14/2012EP2427425A2 Tetracycline compounds
03/14/2012EP2200982B1 Piperidine derivatives as nk3 receptor antagonists
03/14/2012CN102378739A Method for preparing cha-type molecular sieves using novel structure directing agents
03/14/2012CN102372692A Dihydropyridine derivative
03/13/2012USRE43244 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
03/13/2012US8134015 Compound inhibiting in vivo phosphorous transport and medicine containing the same
03/13/2012US8134009 Process for the oxidation of secondary amines into the corresponding nitroxides
03/13/2012US8134006 Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activity
03/13/2012US8134003 Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
03/13/2012US8133904 Cannabinoid receptor antagonists/inverse agonists useful for treating obesity
03/08/2012WO2012030106A2 Production method of intermediate compound for synthesizing medicament
03/08/2012WO2012028635A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
03/08/2012WO2012028614A1 5-ht2b receptor antagonists
03/08/2012WO2012000608A3 Novel beta-aminoaldehyde derivatives, process for their preparation and their chemical use as reactive intermediates
03/08/2012WO2011121099A3 Process for the preparation of 1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(diphenylmethoxy)-1-piperidinyl]-1-butanone and acid addition salts thereof
03/08/2012WO2003032894A3 Method of monitoring neuroprotective treatment
03/08/2012US20120059004 Compounds And Compositions For Treating Cancer
03/08/2012US20120059003 Inhibitors of inv(16) leukemia
03/08/2012US20120058982 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012CA2810393A1 Method of preparing 3-amino-4-(2-oxo-piperidin-1-yl)-butyric acid derivative for synthesizing medicament
03/08/2012CA2810092A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
03/08/2012CA2806647A1 5-ht2b receptor antagonists
03/07/2012EP2426154A1 Photosensitive composition, pattern forming method using the photosensitive composition and compound for use in the photosensitive composition
03/07/2012EP2426107A1 Transition metal conjugated radiopharmaceuticals useful as therapeutic and/or diagnostic agents
03/07/2012EP1694644B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN102369186A Piperidine and piperazine derivatives as autotaxin inhibitors
03/07/2012CN102367236A Synthesizing technology of donepezil hydrochloride
03/07/2012CN101316820B Process for preparation of chiral amlodipine gentisate
03/07/2012CN101094834B Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129534 Chemical compounds
03/06/2012US8129409 Piperidine derivatives and cosmetic compositions thereof
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129406 Nonpeptide inhibitors of matrix metalloproteinases
03/06/2012US8129376 Piperidine derivatives as inhibitors of stearoyl-CoA desaturase
03/06/2012US8129358 Substituted pyrazole and triazole compounds as KSP inhibitors
03/06/2012US8129355 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
03/06/2012CA2406720C Nitroaromatic solubilizer for nitroxyls in aromatic solvents
03/01/2012WO2012026914A1 Methods and compositions for treating internal and external hemorrhoids
03/01/2012WO2012025155A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2011151247A3 Pesticidal compositions
03/01/2012WO2011084705A3 Chemical reagents for the activation of polysaccharides in the preparation of conjugate vaccines
03/01/2012US20120053350 Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
03/01/2012US20120053208 Curcumin Analogs as Dual JAK2/STAT3 Inhibitors and Methods of Making and Using the Same
03/01/2012US20120053180 Cyclohexane analogues as gpr119 agonists
03/01/2012US20120050945 Low viscosity ionic liquids
02/2012
02/29/2012EP2421830A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP2421829A2 2,5-disubstituted arylsulfonamide ccr3 antagonists
02/29/2012EP2421828A2 Piperidine derivatives as inhibitors of renin
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 380